current glp-1 drugs Chart: 1 in 8 Americans Now Use for Weight Loss Comparing Ozempic, Wegovy and Other
Description
2024;6:ojae069
And then the question of is there straight chronic weight management in the elderly becomes less important over time? And so, this [reimbursement] will play out over time on both as we look at data and outcomes to drive further expansion of access. I think the affordability aspect is simply a matter of time
Clin Transpl
For patients where cardiovascular protection is the primary concern, both are reasonable choices, though semaglutides data may suggest greater benefit
What to know Obesity is a known risk factor for breast cancer, so could some women reduce their odds of this common type of cancer by taking weight-loss drugs such as Wegovy and Zepbound
Your medical team will recommend the best option based on your goals and health profile
